Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-12-27 5:23 pm Sale |
2024-12-23 | 13D | Stoke Therapeutics, Inc. STOK |
Skorpios Trust | 6,906,181 13.000% |
-2,000,000 (-22.46%) |
Filing History |
| 2024-09-23 4:22 pm Sale |
2024-09-19 | 13D | Stoke Therapeutics, Inc. STOK |
Skorpios Trust | 8,906,181 16.900% |
-1,937,500 (-17.87%) |
Filing History |
| 2024-04-18 4:18 pm Sale |
2024-04-17 | 13D | Stoke Therapeutics, Inc. STOK |
Skorpios Trust | 10,843,681 23.400% |
-3,600,000 (-24.92%) |
Filing History |
| 2023-09-12 4:30 pm Sale |
2023-09-08 | 13G | Akero Therapeutics, Inc. AKRO |
Skorpios Trust | 0 0.000% |
-3,271,829 (Position Closed) |
Filing History |
| 2022-12-05 4:40 pm Sale |
2022-12-01 | 13G | Akero Therapeutics, Inc. AKRO |
Skorpios Trust | 3,271,829 7.000% |
-1,636,000 (-33.33%) |
Filing History |
| 2021-06-30 4:19 pm Purchase |
2021-06-21 | 13D | Stoke Therapeutics, Inc. STOK |
Skorpios Trust | 14,443,681 39.300% |
14,443,681 (New Position) |
Filing History |
| 2021-06-30 4:17 pm Purchase |
2021-06-21 | 13G | Akero Therapeutics, Inc. AKRO |
Skorpios Trust | 4,907,829 14.100% |
4,907,829 (New Position) |
Filing History |